The major human immunodeficiency virus type 2 (HIV-2) packaging signal is present on all HIV-2 RNA species: Cotranslational RNA encapsidation and limitation of Gag protein confer specificity

被引:77
|
作者
Griffin, SDC [1 ]
Allen, JF [1 ]
Lever, AML [1 ]
机构
[1] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England
关键词
D O I
10.1128/JVI.75.24.12058-12069.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Deletion of a region of the human immunodeficiency virus type 2 (HIV-2) 5' leader RNA reduces genomic RNA encapsidation to about 5% that of wild-type virus with no defect in viral protein production but severely limits virus spread in Jurkat T cells, indicating that this region contains a major cis-acting encapsidation signal, or psi (psi). Being upstream of the major splice donor, it is present on all viral transcripts. We have shown that HIV-2 selects its genomic RNA for encapsidation cotranslationally, rendering wild-type HIV-2 unable to encapsidate vector RNAs in trans. Virus with psi deleted, however, encapsidates an HIV-2 vector, demonstrating competition for Gag protein. HIV-2 overcomes the lack of packaging signal location specificity by two novel mechanisms, cotranslational packaging and competition for limiting Gag polyprotein.
引用
收藏
页码:12058 / 12069
页数:12
相关论文
共 50 条
  • [21] Human immunodeficiency virus (HIV) type-1, HIV-2 and simian immunodeficiency virus Nef proteins
    Laguette, Nadine
    Bregnard, Christelle
    Benichou, Serge
    Basmaciogullari, Stephane
    MOLECULAR ASPECTS OF MEDICINE, 2010, 31 (05) : 418 - 433
  • [22] INFECTION OF BABOONS WITH HUMAN IMMUNODEFICIENCY VIRUS-2 (HIV-2)
    LETVIN, NL
    DANIEL, MD
    SEHGAL, PK
    YETZ, JM
    SOLOMON, KR
    KANNAGI, M
    SCHMIDT, DK
    SILVA, DP
    MONTAGNIER, L
    DESROSIERS, RC
    JOURNAL OF INFECTIOUS DISEASES, 1987, 156 (02): : 406 - 407
  • [23] MONOCLONAL-ANTIBODIES DIRECTED AGAINST HUMAN IMMUNODEFICIENCY VIRUS (HIV) GAG PROTEINS WITH SPECIFICITY FOR CONSERVED EPITOPES IN HIV-1, HIV-2 AND SIMIAN IMMUNODEFICIENCY VIRUS
    NIEDRIG, M
    RABANUS, JP
    LAGESTEHR, J
    GELDERBLOM, HR
    PAULI, G
    JOURNAL OF GENERAL VIROLOGY, 1988, 69 : 2109 - 2114
  • [24] Detection of human immunodeficiency virus type 1 (HIV-1) RNA in pools of sera negative for antibodies to HIV-1 and HIV-2
    Morandi, PA
    Schockmel, GA
    Yerly, S
    Burgisser, P
    Erb, P
    Matter, L
    Sitavanc, R
    Perrin, L
    JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (06) : 1534 - 1538
  • [25] BIOLOGIC HETEROGENEITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 (HIV-2) STRAINS
    CASTRO, BA
    BARNETT, SW
    EVANS, LA
    MOREAU, J
    ODEHOURI, K
    LEVY, JA
    VIROLOGY, 1990, 178 (02) : 527 - 534
  • [26] Computational studies of inhibitor binding to human immunodeficiency virus, Type 2 (HIV-2) protease
    Summay, Russell
    Waingeh, Victor
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 249
  • [27] Variability of human immunodeficiency virus type 2 (HIV-2) infecting patients living in France
    Damond, F
    Apetrei, C
    Robertson, DL
    Souquière, S
    Leprêtre, A
    Matheron, S
    Plantier, JC
    Brun-Vézinet, F
    Simon, F
    VIROLOGY, 2001, 280 (01) : 19 - 30
  • [28] Human immunodeficiency virus type 2 (HIV-2) seroprevalence and characterization of a distinct HIV-2 genetic subtype from the natural range of simian immunodeficiency virus-infected sooty mangabeys
    Chen, ZW
    Luckay, A
    Sodora, DL
    Telfer, P
    Reed, P
    Gettie, A
    Kanu, JM
    Zhang, LQ
    Sadek, RF
    Yee, J
    Ho, DD
    Marx, PA
    JOURNAL OF VIROLOGY, 1997, 71 (05) : 3953 - 3960
  • [29] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-II (HIV-2) TESTING - A PERSPECTIVE
    GLASSMAN, AB
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 1992, 22 (05): : 283 - 285
  • [30] Human Immunodeficiency Virus Type 2 (HIV-2) Gag Is Trafficked in an AP-3 and AP-5 Dependent Manner
    Alford, Justine E.
    Marongiu, Michela
    Watkins, Gemma L.
    Anderson, Emma C.
    PLOS ONE, 2016, 11 (07):